Article

Send us your personal finance questions

Send us a question about estate planning, retirement, or investing.

Have a question about estate planning, retirement, or investing? Send your question to Joel M. Blau, CFP, and Ronald J. Paprocki, JD, CFP, CHBC, c/o Urology Times. To submit your question, use the "Post a Comment" form below.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
DNA helix | Image Credit: © Radomir Jovanovic - stock.adobe.com
Related Content
CMS issues reimbursement code for PSMA-PET imaging agent Gozellix
July 15th 2025

CMS issues reimbursement code for PSMA-PET imaging agent Gozellix

Hannah Clarke
The level II code A9616 will be effective starting on October 1, 2025.
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
July 15th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD
Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.
Study shows favorable outcomes with guideline-based treatment for localized prostate cancer
July 14th 2025

Study shows favorable outcomes with guideline-based treatment for localized prostate cancer

Hannah Clarke
“Our data support adherence to guideline recommendations for treatment of prostate cancer,” says Pietro Scilipoti, MD.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
Patient talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
July 10th 2025

FDA grants breakthrough device designation for ArteraAI Prostate tool

Benjamin P. Saylor Hannah Clarke
“This designation is a powerful validation of our software's potential to transform how we treat cancer,” said Andre Esteva, CEO of Artera.
Data supports combination intravesical chemotherapy for high-risk NMIBC
July 10th 2025

Data supports combination intravesical chemotherapy for high-risk NMIBC

Hannah Clarke
“This study adds to the growing body of evidence supporting combination intravesical chemotherapy as a feasible option even after prior treatment failure," says Ian M. McElree, MD.
© 2025 MJH Life Sciences

All rights reserved.